nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCC2—Olmesartan—coronary artery disease	0.0652	0.0915	CbGbCtD
Sparfloxacin—SLC22A5—Niacin—coronary artery disease	0.058	0.0814	CbGbCtD
Sparfloxacin—ABCC2—Pitavastatin—coronary artery disease	0.0521	0.0731	CbGbCtD
Sparfloxacin—ABCC2—Telmisartan—coronary artery disease	0.0521	0.0731	CbGbCtD
Sparfloxacin—ABCC2—Ezetimibe—coronary artery disease	0.0384	0.0539	CbGbCtD
Sparfloxacin—SLC22A5—Furosemide—coronary artery disease	0.0382	0.0536	CbGbCtD
Sparfloxacin—ABCC2—Simvastatin—coronary artery disease	0.0357	0.0501	CbGbCtD
Sparfloxacin—ABCC2—Lovastatin—coronary artery disease	0.035	0.0491	CbGbCtD
Sparfloxacin—ABCC2—Pravastatin—coronary artery disease	0.035	0.0491	CbGbCtD
Sparfloxacin—ABCC2—Atorvastatin—coronary artery disease	0.0318	0.0447	CbGbCtD
Sparfloxacin—ABCB1—Ticagrelor—coronary artery disease	0.0315	0.0441	CbGbCtD
Sparfloxacin—ABCC2—Furosemide—coronary artery disease	0.0297	0.0417	CbGbCtD
Sparfloxacin—ABCB1—Perindopril—coronary artery disease	0.0194	0.0273	CbGbCtD
Sparfloxacin—ABCB1—Clopidogrel—coronary artery disease	0.0194	0.0273	CbGbCtD
Sparfloxacin—ABCB1—Telmisartan—coronary artery disease	0.017	0.0238	CbGbCtD
Sparfloxacin—ABCB1—Pitavastatin—coronary artery disease	0.017	0.0238	CbGbCtD
Sparfloxacin—ABCB1—Lisinopril—coronary artery disease	0.0161	0.0226	CbGbCtD
Sparfloxacin—ABCB1—Enalapril—coronary artery disease	0.0161	0.0226	CbGbCtD
Sparfloxacin—ABCB1—Timolol—coronary artery disease	0.0137	0.0192	CbGbCtD
Sparfloxacin—ABCB1—Ezetimibe—coronary artery disease	0.0125	0.0176	CbGbCtD
Sparfloxacin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0122	0.0171	CbGbCtD
Sparfloxacin—ABCB1—Captopril—coronary artery disease	0.0121	0.0169	CbGbCtD
Sparfloxacin—ABCB1—Simvastatin—coronary artery disease	0.0116	0.0163	CbGbCtD
Sparfloxacin—ABCB1—Pravastatin—coronary artery disease	0.0114	0.016	CbGbCtD
Sparfloxacin—ABCB1—Lovastatin—coronary artery disease	0.0114	0.016	CbGbCtD
Sparfloxacin—ABCB1—Atorvastatin—coronary artery disease	0.0104	0.0146	CbGbCtD
Sparfloxacin—ABCB1—Losartan—coronary artery disease	0.00949	0.0133	CbGbCtD
Sparfloxacin—TOP2A—Fluvastatin—Pitavastatin—coronary artery disease	0.00071	0.193	CbGdCrCtD
Sparfloxacin—TOP2A—Fluvastatin—Rosuvastatin—coronary artery disease	0.000633	0.172	CbGdCrCtD
Sparfloxacin—TOP2A—Simvastatin—Lovastatin—coronary artery disease	0.000605	0.164	CbGdCrCtD
Sparfloxacin—TOP2A—Simvastatin—Pravastatin—coronary artery disease	0.000605	0.164	CbGdCrCtD
Sparfloxacin—TOP2A—Fluvastatin—Atorvastatin—coronary artery disease	0.000538	0.146	CbGdCrCtD
Sparfloxacin—TOP2A—Alprenolol—Penbutolol—coronary artery disease	0.000346	0.0942	CbGdCrCtD
Sparfloxacin—TOP2A—Methyltestosterone—Eplerenone—coronary artery disease	0.000241	0.0655	CbGdCrCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—COX5B—coronary artery disease	6.61e-05	0.00178	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—RYR2—coronary artery disease	6.61e-05	0.00178	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TMPO—coronary artery disease	6.51e-05	0.00175	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—coronary artery disease	6.44e-05	0.00173	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLN—coronary artery disease	6.43e-05	0.00173	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—HK1—coronary artery disease	6.42e-05	0.00173	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	6.42e-05	0.00173	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG5—coronary artery disease	6.42e-05	0.00173	CbGpPWpGaD
Sparfloxacin—Rash—Lovastatin—coronary artery disease	6.41e-05	0.00026	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—AGTR1—coronary artery disease	6.41e-05	0.00172	CbGpPWpGaD
Sparfloxacin—Dermatitis—Lovastatin—coronary artery disease	6.4e-05	0.00026	CcSEcCtD
Sparfloxacin—Dyspepsia—Losartan—coronary artery disease	6.39e-05	0.000259	CcSEcCtD
Sparfloxacin—Feeling abnormal—Perindopril—coronary artery disease	6.38e-05	0.000259	CcSEcCtD
Sparfloxacin—Headache—Lovastatin—coronary artery disease	6.37e-05	0.000258	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—LEP—coronary artery disease	6.36e-05	0.00171	CbGpPWpGaD
Sparfloxacin—Pruritus—Valsartan—coronary artery disease	6.35e-05	0.000258	CcSEcCtD
Sparfloxacin—Dry mouth—Ramipril—coronary artery disease	6.35e-05	0.000258	CcSEcCtD
Sparfloxacin—Arthralgia—Timolol—coronary artery disease	6.35e-05	0.000258	CcSEcCtD
Sparfloxacin—Chest pain—Timolol—coronary artery disease	6.35e-05	0.000258	CcSEcCtD
Sparfloxacin—Myalgia—Timolol—coronary artery disease	6.35e-05	0.000258	CcSEcCtD
Sparfloxacin—Vomiting—Ezetimibe—coronary artery disease	6.34e-05	0.000257	CcSEcCtD
Sparfloxacin—Hypersensitivity—Pravastatin—coronary artery disease	6.33e-05	0.000257	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Perindopril—coronary artery disease	6.33e-05	0.000257	CcSEcCtD
Sparfloxacin—Anxiety—Timolol—coronary artery disease	6.33e-05	0.000257	CcSEcCtD
Sparfloxacin—Angioedema—Lisinopril—coronary artery disease	6.32e-05	0.000256	CcSEcCtD
Sparfloxacin—Pruritus—Olmesartan—coronary artery disease	6.32e-05	0.000256	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—coronary artery disease	6.32e-05	0.0017	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Losartan—coronary artery disease	6.31e-05	0.000256	CcSEcCtD
Sparfloxacin—Body temperature increased—Captopril—coronary artery disease	6.3e-05	0.000256	CcSEcCtD
Sparfloxacin—Abdominal pain—Captopril—coronary artery disease	6.3e-05	0.000256	CcSEcCtD
Sparfloxacin—Dizziness—Simvastatin—coronary artery disease	6.29e-05	0.000255	CcSEcCtD
Sparfloxacin—Rash—Ezetimibe—coronary artery disease	6.29e-05	0.000255	CcSEcCtD
Sparfloxacin—Dermatitis—Ezetimibe—coronary artery disease	6.28e-05	0.000255	CcSEcCtD
Sparfloxacin—Confusional state—Ramipril—coronary artery disease	6.28e-05	0.000255	CcSEcCtD
Sparfloxacin—Discomfort—Timolol—coronary artery disease	6.28e-05	0.000255	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—coronary artery disease	6.27e-05	0.00169	CbGpPWpGaD
Sparfloxacin—Asthenia—Niacin—coronary artery disease	6.26e-05	0.000254	CcSEcCtD
Sparfloxacin—Headache—Ezetimibe—coronary artery disease	6.25e-05	0.000253	CcSEcCtD
Sparfloxacin—Malaise—Lisinopril—coronary artery disease	6.24e-05	0.000253	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Ramipril—coronary artery disease	6.23e-05	0.000253	CcSEcCtD
Sparfloxacin—Vertigo—Lisinopril—coronary artery disease	6.22e-05	0.000252	CcSEcCtD
Sparfloxacin—Dry mouth—Timolol—coronary artery disease	6.21e-05	0.000252	CcSEcCtD
Sparfloxacin—Constipation—Losartan—coronary artery disease	6.21e-05	0.000252	CcSEcCtD
Sparfloxacin—Pain—Losartan—coronary artery disease	6.21e-05	0.000252	CcSEcCtD
Sparfloxacin—Vomiting—Eplerenone—coronary artery disease	6.21e-05	0.000252	CcSEcCtD
Sparfloxacin—Feeling abnormal—Furosemide—coronary artery disease	6.2e-05	0.000252	CcSEcCtD
Sparfloxacin—Nausea—Fenofibrate—coronary artery disease	6.18e-05	0.000251	CcSEcCtD
Sparfloxacin—Pruritus—Niacin—coronary artery disease	6.18e-05	0.000251	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—coronary artery disease	6.17e-05	0.00166	CbGpPWpGaD
Sparfloxacin—Asthenia—Pravastatin—coronary artery disease	6.17e-05	0.00025	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Furosemide—coronary artery disease	6.16e-05	0.00025	CcSEcCtD
Sparfloxacin—Rash—Eplerenone—coronary artery disease	6.15e-05	0.00025	CcSEcCtD
Sparfloxacin—Urticaria—Perindopril—coronary artery disease	6.15e-05	0.00025	CcSEcCtD
Sparfloxacin—Hypersensitivity—Trandolapril—coronary artery disease	6.15e-05	0.000249	CcSEcCtD
Sparfloxacin—Dermatitis—Eplerenone—coronary artery disease	6.15e-05	0.000249	CcSEcCtD
Sparfloxacin—Diarrhoea—Valsartan—coronary artery disease	6.14e-05	0.000249	CcSEcCtD
Sparfloxacin—Confusional state—Timolol—coronary artery disease	6.14e-05	0.000249	CcSEcCtD
Sparfloxacin—Hypersensitivity—Enalapril—coronary artery disease	6.13e-05	0.000248	CcSEcCtD
Sparfloxacin—Body temperature increased—Perindopril—coronary artery disease	6.12e-05	0.000248	CcSEcCtD
Sparfloxacin—Abdominal pain—Perindopril—coronary artery disease	6.12e-05	0.000248	CcSEcCtD
Sparfloxacin—Palpitations—Lisinopril—coronary artery disease	6.12e-05	0.000248	CcSEcCtD
Sparfloxacin—Diarrhoea—Olmesartan—coronary artery disease	6.12e-05	0.000248	CcSEcCtD
Sparfloxacin—Headache—Eplerenone—coronary artery disease	6.11e-05	0.000248	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Ramipril—coronary artery disease	6.1e-05	0.000247	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Timolol—coronary artery disease	6.09e-05	0.000247	CcSEcCtD
Sparfloxacin—Pruritus—Pravastatin—coronary artery disease	6.08e-05	0.000247	CcSEcCtD
Sparfloxacin—Nausea—Clopidogrel—coronary artery disease	6.08e-05	0.000247	CcSEcCtD
Sparfloxacin—Tachycardia—Ramipril—coronary artery disease	6.08e-05	0.000247	CcSEcCtD
Sparfloxacin—Vomiting—Simvastatin—coronary artery disease	6.05e-05	0.000245	CcSEcCtD
Sparfloxacin—Hypersensitivity—Telmisartan—coronary artery disease	6.04e-05	0.000245	CcSEcCtD
Sparfloxacin—Cough—Lisinopril—coronary artery disease	6.04e-05	0.000245	CcSEcCtD
Sparfloxacin—Nausea—Lovastatin—coronary artery disease	6.04e-05	0.000245	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Ramipril—coronary artery disease	6.02e-05	0.000244	CcSEcCtD
Sparfloxacin—Rash—Simvastatin—coronary artery disease	6e-05	0.000243	CcSEcCtD
Sparfloxacin—Dermatitis—Simvastatin—coronary artery disease	5.99e-05	0.000243	CcSEcCtD
Sparfloxacin—Asthenia—Trandolapril—coronary artery disease	5.99e-05	0.000243	CcSEcCtD
Sparfloxacin—Feeling abnormal—Losartan—coronary artery disease	5.99e-05	0.000243	CcSEcCtD
Sparfloxacin—Urticaria—Furosemide—coronary artery disease	5.98e-05	0.000243	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HK2—coronary artery disease	5.98e-05	0.00161	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Niacin—coronary artery disease	5.97e-05	0.000242	CcSEcCtD
Sparfloxacin—Asthenia—Enalapril—coronary artery disease	5.97e-05	0.000242	CcSEcCtD
Sparfloxacin—Headache—Simvastatin—coronary artery disease	5.96e-05	0.000242	CcSEcCtD
Sparfloxacin—Body temperature increased—Furosemide—coronary artery disease	5.95e-05	0.000241	CcSEcCtD
Sparfloxacin—Abdominal pain—Furosemide—coronary artery disease	5.95e-05	0.000241	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Losartan—coronary artery disease	5.94e-05	0.000241	CcSEcCtD
Sparfloxacin—Dizziness—Valsartan—coronary artery disease	5.94e-05	0.000241	CcSEcCtD
Sparfloxacin—Anorexia—Ramipril—coronary artery disease	5.94e-05	0.000241	CcSEcCtD
Sparfloxacin—Nausea—Ezetimibe—coronary artery disease	5.92e-05	0.00024	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—NOS2—coronary artery disease	5.92e-05	0.00159	CbGpPWpGaD
Sparfloxacin—Dizziness—Olmesartan—coronary artery disease	5.91e-05	0.00024	CcSEcCtD
Sparfloxacin—Pruritus—Trandolapril—coronary artery disease	5.91e-05	0.00024	CcSEcCtD
Sparfloxacin—Myalgia—Lisinopril—coronary artery disease	5.89e-05	0.000239	CcSEcCtD
Sparfloxacin—Arthralgia—Lisinopril—coronary artery disease	5.89e-05	0.000239	CcSEcCtD
Sparfloxacin—Chest pain—Lisinopril—coronary artery disease	5.89e-05	0.000239	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Timolol—coronary artery disease	5.89e-05	0.000239	CcSEcCtD
Sparfloxacin—Asthenia—Telmisartan—coronary artery disease	5.88e-05	0.000239	CcSEcCtD
Sparfloxacin—Pruritus—Enalapril—coronary artery disease	5.88e-05	0.000239	CcSEcCtD
Sparfloxacin—Diarrhoea—Pravastatin—coronary artery disease	5.88e-05	0.000239	CcSEcCtD
Sparfloxacin—Anxiety—Lisinopril—coronary artery disease	5.87e-05	0.000238	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—coronary artery disease	5.84e-05	0.00157	CbGpPWpGaD
Sparfloxacin—Discomfort—Lisinopril—coronary artery disease	5.82e-05	0.000236	CcSEcCtD
Sparfloxacin—Anorexia—Timolol—coronary artery disease	5.8e-05	0.000235	CcSEcCtD
Sparfloxacin—Pruritus—Telmisartan—coronary artery disease	5.8e-05	0.000235	CcSEcCtD
Sparfloxacin—Nausea—Eplerenone—coronary artery disease	5.8e-05	0.000235	CcSEcCtD
Sparfloxacin—Dizziness—Niacin—coronary artery disease	5.77e-05	0.000234	CcSEcCtD
Sparfloxacin—Urticaria—Losartan—coronary artery disease	5.77e-05	0.000234	CcSEcCtD
Sparfloxacin—Dry mouth—Lisinopril—coronary artery disease	5.76e-05	0.000234	CcSEcCtD
Sparfloxacin—Body temperature increased—Losartan—coronary artery disease	5.74e-05	0.000233	CcSEcCtD
Sparfloxacin—Abdominal pain—Losartan—coronary artery disease	5.74e-05	0.000233	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	5.73e-05	0.00154	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	5.73e-05	0.00154	CbGpPWpGaD
Sparfloxacin—Asthenia—Captopril—coronary artery disease	5.72e-05	0.000232	CcSEcCtD
Sparfloxacin—Diarrhoea—Trandolapril—coronary artery disease	5.71e-05	0.000232	CcSEcCtD
Sparfloxacin—Vomiting—Valsartan—coronary artery disease	5.71e-05	0.000232	CcSEcCtD
Sparfloxacin—Confusional state—Lisinopril—coronary artery disease	5.7e-05	0.000231	CcSEcCtD
Sparfloxacin—Diarrhoea—Enalapril—coronary artery disease	5.69e-05	0.000231	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—coronary artery disease	5.69e-05	0.00153	CbGpPWpGaD
Sparfloxacin—Dizziness—Pravastatin—coronary artery disease	5.69e-05	0.000231	CcSEcCtD
Sparfloxacin—Vomiting—Olmesartan—coronary artery disease	5.68e-05	0.00023	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.67e-05	0.00023	CcSEcCtD
Sparfloxacin—Rash—Valsartan—coronary artery disease	5.66e-05	0.00023	CcSEcCtD
Sparfloxacin—Dermatitis—Valsartan—coronary artery disease	5.66e-05	0.000229	CcSEcCtD
Sparfloxacin—Nausea—Simvastatin—coronary artery disease	5.65e-05	0.000229	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Lisinopril—coronary artery disease	5.65e-05	0.000229	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PSMB5—coronary artery disease	5.65e-05	0.00152	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PSMA6—coronary artery disease	5.65e-05	0.00152	CbGpPWpGaD
Sparfloxacin—Pruritus—Captopril—coronary artery disease	5.64e-05	0.000229	CcSEcCtD
Sparfloxacin—Rash—Olmesartan—coronary artery disease	5.64e-05	0.000229	CcSEcCtD
Sparfloxacin—Insomnia—Ramipril—coronary artery disease	5.63e-05	0.000228	CcSEcCtD
Sparfloxacin—Dermatitis—Olmesartan—coronary artery disease	5.63e-05	0.000228	CcSEcCtD
Sparfloxacin—Headache—Valsartan—coronary artery disease	5.63e-05	0.000228	CcSEcCtD
Sparfloxacin—Diarrhoea—Telmisartan—coronary artery disease	5.61e-05	0.000228	CcSEcCtD
Sparfloxacin—Headache—Olmesartan—coronary artery disease	5.6e-05	0.000227	CcSEcCtD
Sparfloxacin—Paraesthesia—Ramipril—coronary artery disease	5.59e-05	0.000227	CcSEcCtD
Sparfloxacin—Asthenia—Perindopril—coronary artery disease	5.56e-05	0.000225	CcSEcCtD
Sparfloxacin—Dyspnoea—Ramipril—coronary artery disease	5.55e-05	0.000225	CcSEcCtD
Sparfloxacin—Vomiting—Niacin—coronary artery disease	5.55e-05	0.000225	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Timolol—coronary artery disease	5.55e-05	0.000225	CcSEcCtD
Sparfloxacin—Hypersensitivity—Furosemide—coronary artery disease	5.55e-05	0.000225	CcSEcCtD
Sparfloxacin—Somnolence—Ramipril—coronary artery disease	5.54e-05	0.000225	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPARG—coronary artery disease	5.54e-05	0.00149	CbGpPWpGaD
Sparfloxacin—Thrombocytopenia—Lisinopril—coronary artery disease	5.53e-05	0.000224	CcSEcCtD
Sparfloxacin—Dizziness—Trandolapril—coronary artery disease	5.52e-05	0.000224	CcSEcCtD
Sparfloxacin—Tachycardia—Lisinopril—coronary artery disease	5.51e-05	0.000224	CcSEcCtD
Sparfloxacin—Insomnia—Timolol—coronary artery disease	5.51e-05	0.000223	CcSEcCtD
Sparfloxacin—Rash—Niacin—coronary artery disease	5.51e-05	0.000223	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—GSK3B—coronary artery disease	5.5e-05	0.00148	CbGpPWpGaD
Sparfloxacin—Dermatitis—Niacin—coronary artery disease	5.5e-05	0.000223	CcSEcCtD
Sparfloxacin—Dizziness—Enalapril—coronary artery disease	5.5e-05	0.000223	CcSEcCtD
Sparfloxacin—Dyspepsia—Ramipril—coronary artery disease	5.48e-05	0.000222	CcSEcCtD
Sparfloxacin—Pruritus—Perindopril—coronary artery disease	5.48e-05	0.000222	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—coronary artery disease	5.47e-05	0.00147	CbGpPWpGaD
Sparfloxacin—Headache—Niacin—coronary artery disease	5.47e-05	0.000222	CcSEcCtD
Sparfloxacin—Paraesthesia—Timolol—coronary artery disease	5.47e-05	0.000222	CcSEcCtD
Sparfloxacin—Vomiting—Pravastatin—coronary artery disease	5.47e-05	0.000222	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Lisinopril—coronary artery disease	5.46e-05	0.000221	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—CREB1—coronary artery disease	5.46e-05	0.00147	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Captopril—coronary artery disease	5.46e-05	0.000221	CcSEcCtD
Sparfloxacin—Dyspnoea—Timolol—coronary artery disease	5.43e-05	0.00022	CcSEcCtD
Sparfloxacin—Dizziness—Telmisartan—coronary artery disease	5.42e-05	0.00022	CcSEcCtD
Sparfloxacin—Rash—Pravastatin—coronary artery disease	5.42e-05	0.00022	CcSEcCtD
Sparfloxacin—Dermatitis—Pravastatin—coronary artery disease	5.42e-05	0.00022	CcSEcCtD
Sparfloxacin—Decreased appetite—Ramipril—coronary artery disease	5.41e-05	0.00022	CcSEcCtD
Sparfloxacin—Somnolence—Timolol—coronary artery disease	5.41e-05	0.00022	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—coronary artery disease	5.41e-05	0.00145	CbGpPWpGaD
Sparfloxacin—Asthenia—Furosemide—coronary artery disease	5.4e-05	0.000219	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—IL1A—coronary artery disease	5.4e-05	0.00145	CbGpPWpGaD
Sparfloxacin—Headache—Pravastatin—coronary artery disease	5.39e-05	0.000218	CcSEcCtD
Sparfloxacin—Anorexia—Lisinopril—coronary artery disease	5.38e-05	0.000218	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—IL10—coronary artery disease	5.37e-05	0.00144	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD40LG—coronary artery disease	5.37e-05	0.00144	CbGpPWpGaD
Sparfloxacin—Dyspepsia—Timolol—coronary artery disease	5.36e-05	0.000217	CcSEcCtD
Sparfloxacin—Hypersensitivity—Losartan—coronary artery disease	5.35e-05	0.000217	CcSEcCtD
Sparfloxacin—Nausea—Valsartan—coronary artery disease	5.33e-05	0.000216	CcSEcCtD
Sparfloxacin—Pruritus—Furosemide—coronary artery disease	5.33e-05	0.000216	CcSEcCtD
Sparfloxacin—Constipation—Ramipril—coronary artery disease	5.33e-05	0.000216	CcSEcCtD
Sparfloxacin—Nausea—Olmesartan—coronary artery disease	5.31e-05	0.000215	CcSEcCtD
Sparfloxacin—Vomiting—Trandolapril—coronary artery disease	5.31e-05	0.000215	CcSEcCtD
Sparfloxacin—Diarrhoea—Perindopril—coronary artery disease	5.3e-05	0.000215	CcSEcCtD
Sparfloxacin—Decreased appetite—Timolol—coronary artery disease	5.29e-05	0.000215	CcSEcCtD
Sparfloxacin—Vomiting—Enalapril—coronary artery disease	5.29e-05	0.000214	CcSEcCtD
Sparfloxacin—Dizziness—Captopril—coronary artery disease	5.27e-05	0.000214	CcSEcCtD
Sparfloxacin—Rash—Trandolapril—coronary artery disease	5.26e-05	0.000214	CcSEcCtD
Sparfloxacin—Dermatitis—Trandolapril—coronary artery disease	5.26e-05	0.000213	CcSEcCtD
Sparfloxacin—Rash—Enalapril—coronary artery disease	5.24e-05	0.000213	CcSEcCtD
Sparfloxacin—Dermatitis—Enalapril—coronary artery disease	5.24e-05	0.000212	CcSEcCtD
Sparfloxacin—Headache—Trandolapril—coronary artery disease	5.23e-05	0.000212	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—coronary artery disease	5.22e-05	0.00141	CbGpPWpGaD
Sparfloxacin—Vomiting—Telmisartan—coronary artery disease	5.21e-05	0.000212	CcSEcCtD
Sparfloxacin—Asthenia—Losartan—coronary artery disease	5.21e-05	0.000211	CcSEcCtD
Sparfloxacin—Headache—Enalapril—coronary artery disease	5.21e-05	0.000211	CcSEcCtD
Sparfloxacin—Pain—Timolol—coronary artery disease	5.21e-05	0.000211	CcSEcCtD
Sparfloxacin—Nausea—Niacin—coronary artery disease	5.19e-05	0.00021	CcSEcCtD
Sparfloxacin—Rash—Telmisartan—coronary artery disease	5.17e-05	0.00021	CcSEcCtD
Sparfloxacin—Dermatitis—Telmisartan—coronary artery disease	5.17e-05	0.00021	CcSEcCtD
Sparfloxacin—Diarrhoea—Furosemide—coronary artery disease	5.15e-05	0.000209	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.15e-05	0.000209	CcSEcCtD
Sparfloxacin—Pruritus—Losartan—coronary artery disease	5.14e-05	0.000208	CcSEcCtD
Sparfloxacin—Headache—Telmisartan—coronary artery disease	5.14e-05	0.000208	CcSEcCtD
Sparfloxacin—Feeling abnormal—Ramipril—coronary artery disease	5.13e-05	0.000208	CcSEcCtD
Sparfloxacin—Dizziness—Perindopril—coronary artery disease	5.12e-05	0.000208	CcSEcCtD
Sparfloxacin—Insomnia—Lisinopril—coronary artery disease	5.11e-05	0.000207	CcSEcCtD
Sparfloxacin—Nausea—Pravastatin—coronary artery disease	5.11e-05	0.000207	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—LEP—coronary artery disease	5.1e-05	0.00137	CbGpPWpGaD
Sparfloxacin—Gastrointestinal pain—Ramipril—coronary artery disease	5.09e-05	0.000207	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	5.08e-05	0.00137	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	5.08e-05	0.00137	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Lisinopril—coronary artery disease	5.07e-05	0.000206	CcSEcCtD
Sparfloxacin—Vomiting—Captopril—coronary artery disease	5.07e-05	0.000206	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—PSMB5—coronary artery disease	5.05e-05	0.00136	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PSMA6—coronary artery disease	5.05e-05	0.00136	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Lisinopril—coronary artery disease	5.04e-05	0.000204	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—coronary artery disease	5.03e-05	0.00135	CbGpPWpGaD
Sparfloxacin—Rash—Captopril—coronary artery disease	5.03e-05	0.000204	CcSEcCtD
Sparfloxacin—Dermatitis—Captopril—coronary artery disease	5.02e-05	0.000204	CcSEcCtD
Sparfloxacin—Somnolence—Lisinopril—coronary artery disease	5.02e-05	0.000204	CcSEcCtD
Sparfloxacin—Feeling abnormal—Timolol—coronary artery disease	5.02e-05	0.000204	CcSEcCtD
Sparfloxacin—Headache—Captopril—coronary artery disease	5e-05	0.000203	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—SERPINE1—coronary artery disease	4.99e-05	0.00134	CbGpPWpGaD
Sparfloxacin—Gastrointestinal pain—Timolol—coronary artery disease	4.98e-05	0.000202	CcSEcCtD
Sparfloxacin—Dizziness—Furosemide—coronary artery disease	4.98e-05	0.000202	CcSEcCtD
Sparfloxacin—Dyspepsia—Lisinopril—coronary artery disease	4.97e-05	0.000202	CcSEcCtD
Sparfloxacin—Diarrhoea—Losartan—coronary artery disease	4.97e-05	0.000202	CcSEcCtD
Sparfloxacin—Nausea—Trandolapril—coronary artery disease	4.96e-05	0.000201	CcSEcCtD
Sparfloxacin—Urticaria—Ramipril—coronary artery disease	4.95e-05	0.000201	CcSEcCtD
Sparfloxacin—Nausea—Enalapril—coronary artery disease	4.94e-05	0.0002	CcSEcCtD
Sparfloxacin—Vomiting—Perindopril—coronary artery disease	4.92e-05	0.0002	CcSEcCtD
Sparfloxacin—Body temperature increased—Ramipril—coronary artery disease	4.92e-05	0.0002	CcSEcCtD
Sparfloxacin—Abdominal pain—Ramipril—coronary artery disease	4.92e-05	0.0002	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	4.92e-05	0.00132	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Lisinopril—coronary artery disease	4.91e-05	0.000199	CcSEcCtD
Sparfloxacin—Rash—Perindopril—coronary artery disease	4.88e-05	0.000198	CcSEcCtD
Sparfloxacin—Dermatitis—Perindopril—coronary artery disease	4.88e-05	0.000198	CcSEcCtD
Sparfloxacin—Nausea—Telmisartan—coronary artery disease	4.87e-05	0.000198	CcSEcCtD
Sparfloxacin—Headache—Perindopril—coronary artery disease	4.85e-05	0.000197	CcSEcCtD
Sparfloxacin—Urticaria—Timolol—coronary artery disease	4.84e-05	0.000196	CcSEcCtD
Sparfloxacin—Pain—Lisinopril—coronary artery disease	4.83e-05	0.000196	CcSEcCtD
Sparfloxacin—Constipation—Lisinopril—coronary artery disease	4.83e-05	0.000196	CcSEcCtD
Sparfloxacin—Abdominal pain—Timolol—coronary artery disease	4.81e-05	0.000195	CcSEcCtD
Sparfloxacin—Body temperature increased—Timolol—coronary artery disease	4.81e-05	0.000195	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	4.8e-05	0.00129	CbGpPWpGaD
Sparfloxacin—Dizziness—Losartan—coronary artery disease	4.8e-05	0.000195	CcSEcCtD
Sparfloxacin—Vomiting—Furosemide—coronary artery disease	4.79e-05	0.000194	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—coronary artery disease	4.78e-05	0.00128	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—coronary artery disease	4.75e-05	0.00128	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CETP—coronary artery disease	4.75e-05	0.00128	CbGpPWpGaD
Sparfloxacin—Rash—Furosemide—coronary artery disease	4.75e-05	0.000193	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—C3—coronary artery disease	4.74e-05	0.00128	CbGpPWpGaD
Sparfloxacin—Dermatitis—Furosemide—coronary artery disease	4.74e-05	0.000192	CcSEcCtD
Sparfloxacin—Nausea—Captopril—coronary artery disease	4.74e-05	0.000192	CcSEcCtD
Sparfloxacin—Headache—Furosemide—coronary artery disease	4.72e-05	0.000191	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	4.69e-05	0.00126	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HK1—coronary artery disease	4.69e-05	0.00126	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	4.69e-05	0.00126	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Lisinopril—coronary artery disease	4.65e-05	0.000189	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Lisinopril—coronary artery disease	4.62e-05	0.000187	CcSEcCtD
Sparfloxacin—Vomiting—Losartan—coronary artery disease	4.62e-05	0.000187	CcSEcCtD
Sparfloxacin—Nausea—Perindopril—coronary artery disease	4.6e-05	0.000187	CcSEcCtD
Sparfloxacin—Hypersensitivity—Ramipril—coronary artery disease	4.59e-05	0.000186	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—coronary artery disease	4.58e-05	0.00123	CbGpPWpGaD
Sparfloxacin—Rash—Losartan—coronary artery disease	4.58e-05	0.000186	CcSEcCtD
Sparfloxacin—Dermatitis—Losartan—coronary artery disease	4.58e-05	0.000186	CcSEcCtD
Sparfloxacin—Headache—Losartan—coronary artery disease	4.55e-05	0.000185	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	4.54e-05	0.00122	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—coronary artery disease	4.53e-05	0.00122	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—coronary artery disease	4.5e-05	0.00121	CbGpPWpGaD
Sparfloxacin—Urticaria—Lisinopril—coronary artery disease	4.49e-05	0.000182	CcSEcCtD
Sparfloxacin—Hypersensitivity—Timolol—coronary artery disease	4.49e-05	0.000182	CcSEcCtD
Sparfloxacin—Nausea—Furosemide—coronary artery disease	4.47e-05	0.000181	CcSEcCtD
Sparfloxacin—Asthenia—Ramipril—coronary artery disease	4.47e-05	0.000181	CcSEcCtD
Sparfloxacin—Body temperature increased—Lisinopril—coronary artery disease	4.46e-05	0.000181	CcSEcCtD
Sparfloxacin—Abdominal pain—Lisinopril—coronary artery disease	4.46e-05	0.000181	CcSEcCtD
Sparfloxacin—Pruritus—Ramipril—coronary artery disease	4.41e-05	0.000179	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CREB1—coronary artery disease	4.38e-05	0.00118	CbGpPWpGaD
Sparfloxacin—Asthenia—Timolol—coronary artery disease	4.37e-05	0.000177	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	4.36e-05	0.00117	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CRK—coronary artery disease	4.32e-05	0.00116	CbGpPWpGaD
Sparfloxacin—Nausea—Losartan—coronary artery disease	4.31e-05	0.000175	CcSEcCtD
Sparfloxacin—Pruritus—Timolol—coronary artery disease	4.31e-05	0.000175	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—coronary artery disease	4.26e-05	0.00115	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Ramipril—coronary artery disease	4.26e-05	0.000173	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	4.21e-05	0.00113	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—coronary artery disease	4.19e-05	0.00113	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Timolol—coronary artery disease	4.17e-05	0.000169	CcSEcCtD
Sparfloxacin—Hypersensitivity—Lisinopril—coronary artery disease	4.16e-05	0.000169	CcSEcCtD
Sparfloxacin—Dizziness—Ramipril—coronary artery disease	4.12e-05	0.000167	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	4.1e-05	0.0011	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND2—coronary artery disease	4.1e-05	0.0011	CbGpPWpGaD
Sparfloxacin—Asthenia—Lisinopril—coronary artery disease	4.05e-05	0.000164	CcSEcCtD
Sparfloxacin—Dizziness—Timolol—coronary artery disease	4.03e-05	0.000163	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—coronary artery disease	4e-05	0.00108	CbGpPWpGaD
Sparfloxacin—Pruritus—Lisinopril—coronary artery disease	4e-05	0.000162	CcSEcCtD
Sparfloxacin—Vomiting—Ramipril—coronary artery disease	3.96e-05	0.000161	CcSEcCtD
Sparfloxacin—Rash—Ramipril—coronary artery disease	3.93e-05	0.000159	CcSEcCtD
Sparfloxacin—Dermatitis—Ramipril—coronary artery disease	3.92e-05	0.000159	CcSEcCtD
Sparfloxacin—Headache—Ramipril—coronary artery disease	3.9e-05	0.000158	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CFTR—coronary artery disease	3.89e-05	0.00105	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	3.89e-05	0.00105	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—coronary artery disease	3.88e-05	0.00104	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—coronary artery disease	3.88e-05	0.00104	CbGpPWpGaD
Sparfloxacin—Vomiting—Timolol—coronary artery disease	3.87e-05	0.000157	CcSEcCtD
Sparfloxacin—Diarrhoea—Lisinopril—coronary artery disease	3.86e-05	0.000157	CcSEcCtD
Sparfloxacin—Rash—Timolol—coronary artery disease	3.84e-05	0.000156	CcSEcCtD
Sparfloxacin—Dermatitis—Timolol—coronary artery disease	3.84e-05	0.000156	CcSEcCtD
Sparfloxacin—Headache—Timolol—coronary artery disease	3.81e-05	0.000155	CcSEcCtD
Sparfloxacin—Dizziness—Lisinopril—coronary artery disease	3.74e-05	0.000151	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	3.71e-05	0.000997	CbGpPWpGaD
Sparfloxacin—Nausea—Ramipril—coronary artery disease	3.7e-05	0.00015	CcSEcCtD
Sparfloxacin—Nausea—Timolol—coronary artery disease	3.62e-05	0.000147	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	3.6e-05	0.000968	CbGpPWpGaD
Sparfloxacin—Vomiting—Lisinopril—coronary artery disease	3.59e-05	0.000146	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PPP2CA—coronary artery disease	3.59e-05	0.000965	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	3.57e-05	0.000961	CbGpPWpGaD
Sparfloxacin—Rash—Lisinopril—coronary artery disease	3.56e-05	0.000144	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—coronary artery disease	3.56e-05	0.000957	CbGpPWpGaD
Sparfloxacin—Dermatitis—Lisinopril—coronary artery disease	3.56e-05	0.000144	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—coronary artery disease	3.54e-05	0.000953	CbGpPWpGaD
Sparfloxacin—Headache—Lisinopril—coronary artery disease	3.54e-05	0.000144	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	3.51e-05	0.000945	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CETP—coronary artery disease	3.47e-05	0.000934	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—coronary artery disease	3.46e-05	0.00093	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—coronary artery disease	3.43e-05	0.000923	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—coronary artery disease	3.43e-05	0.000923	CbGpPWpGaD
Sparfloxacin—Nausea—Lisinopril—coronary artery disease	3.35e-05	0.000136	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—coronary artery disease	3.29e-05	0.000885	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—coronary artery disease	3.28e-05	0.000883	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	3.28e-05	0.000882	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	3.22e-05	0.000865	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PPP2CA—coronary artery disease	3.21e-05	0.000863	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CA5B—coronary artery disease	3.17e-05	0.000852	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BIRC5—coronary artery disease	3.17e-05	0.000852	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—coronary artery disease	3.15e-05	0.000846	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—RYR2—coronary artery disease	3.11e-05	0.000836	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—COX5B—coronary artery disease	3.11e-05	0.000836	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	3.06e-05	0.000823	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—coronary artery disease	3.06e-05	0.000823	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLN—coronary artery disease	3.02e-05	0.000813	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—coronary artery disease	2.94e-05	0.000789	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—coronary artery disease	2.85e-05	0.000766	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—coronary artery disease	2.82e-05	0.000758	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL1B—coronary artery disease	2.82e-05	0.000757	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HK2—coronary artery disease	2.81e-05	0.000756	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—coronary artery disease	2.81e-05	0.000756	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	2.79e-05	0.00075	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—coronary artery disease	2.76e-05	0.000743	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—coronary artery disease	2.75e-05	0.00074	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CKMT1B—coronary artery disease	2.7e-05	0.000725	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	2.69e-05	0.000725	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	2.69e-05	0.000725	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—coronary artery disease	2.62e-05	0.000704	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLG—coronary artery disease	2.6e-05	0.0007	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—coronary artery disease	2.58e-05	0.000694	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.49e-05	0.000669	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.4e-05	0.000646	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	2.39e-05	0.000643	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	2.39e-05	0.000643	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—coronary artery disease	2.38e-05	0.000641	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—coronary artery disease	2.37e-05	0.000638	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOB—coronary artery disease	2.3e-05	0.000618	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	2.28e-05	0.000613	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HK1—coronary artery disease	2.21e-05	0.000593	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	2.21e-05	0.000593	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	2.21e-05	0.000593	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UQCRFS1—coronary artery disease	2.2e-05	0.000591	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CKM—coronary artery disease	2.2e-05	0.000591	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPAP2B—coronary artery disease	2.2e-05	0.000591	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—coronary artery disease	2.19e-05	0.000588	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—coronary artery disease	2.12e-05	0.00057	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—coronary artery disease	2.08e-05	0.00056	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TNF—coronary artery disease	2.04e-05	0.000549	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT4A1—coronary artery disease	2.04e-05	0.000549	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PYGM—coronary artery disease	2.04e-05	0.000549	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CKMT2—coronary artery disease	2.04e-05	0.000549	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDH6A1—coronary artery disease	2.04e-05	0.000549	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PDK4—coronary artery disease	2.04e-05	0.000549	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—coronary artery disease	2.03e-05	0.000546	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—coronary artery disease	1.98e-05	0.000534	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—coronary artery disease	1.97e-05	0.00053	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—coronary artery disease	1.87e-05	0.000504	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GYG1—coronary artery disease	1.82e-05	0.00049	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMGCS2—coronary artery disease	1.82e-05	0.00049	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PFKM—coronary artery disease	1.82e-05	0.00049	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDHA—coronary artery disease	1.82e-05	0.00049	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GK—coronary artery disease	1.82e-05	0.00049	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GATM—coronary artery disease	1.82e-05	0.00049	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.82e-05	0.000489	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—coronary artery disease	1.8e-05	0.000484	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—coronary artery disease	1.77e-05	0.000477	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—coronary artery disease	1.76e-05	0.000472	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AK1—coronary artery disease	1.74e-05	0.000467	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCH1—coronary artery disease	1.74e-05	0.000467	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.69e-05	0.000455	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPAT—coronary artery disease	1.67e-05	0.000448	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UGCG—coronary artery disease	1.67e-05	0.000448	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLCD1—coronary artery disease	1.67e-05	0.000448	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MDH2—coronary artery disease	1.67e-05	0.000448	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—coronary artery disease	1.66e-05	0.000445	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.65e-05	0.000444	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CETP—coronary artery disease	1.63e-05	0.000439	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PGM1—coronary artery disease	1.6e-05	0.000431	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—coronary artery disease	1.57e-05	0.000423	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—coronary artery disease	1.56e-05	0.000419	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CKB—coronary artery disease	1.55e-05	0.000416	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PYGB—coronary artery disease	1.55e-05	0.000416	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.55e-05	0.000416	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	1.49e-05	0.000402	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—DLAT—coronary artery disease	1.46e-05	0.000391	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLIN1—coronary artery disease	1.46e-05	0.000391	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM2—coronary artery disease	1.46e-05	0.000391	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—COX5B—coronary artery disease	1.46e-05	0.000391	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PFKFB3—coronary artery disease	1.46e-05	0.000391	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—coronary artery disease	1.44e-05	0.000388	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLAT—coronary artery disease	1.44e-05	0.000387	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK1—coronary artery disease	1.39e-05	0.000374	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	1.39e-05	0.000373	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT1E1—coronary artery disease	1.38e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	1.35e-05	0.000363	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKR1B1—coronary artery disease	1.32e-05	0.000354	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HK2—coronary artery disease	1.32e-05	0.000354	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC27A1—coronary artery disease	1.26e-05	0.000339	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LCAT—coronary artery disease	1.24e-05	0.000333	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CPT1B—coronary artery disease	1.24e-05	0.000333	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLG—coronary artery disease	1.22e-05	0.000329	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA4—coronary artery disease	1.21e-05	0.000327	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	1.18e-05	0.000316	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PDHA1—coronary artery disease	1.17e-05	0.000315	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCLM—coronary artery disease	1.17e-05	0.000315	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP11B2—coronary artery disease	1.14e-05	0.000306	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TXNRD1—coronary artery disease	1.14e-05	0.000306	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.13e-05	0.000304	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC22A3—coronary artery disease	1.12e-05	0.000301	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HADH—coronary artery disease	1.1e-05	0.000297	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ARNTL—coronary artery disease	1.1e-05	0.000297	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	1.08e-05	0.000291	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	1.08e-05	0.00029	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	1.06e-05	0.000285	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA2—coronary artery disease	1.05e-05	0.000281	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX2—coronary artery disease	1.05e-05	0.000281	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLA2G2A—coronary artery disease	1.05e-05	0.000281	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HK1—coronary artery disease	1.03e-05	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG5—coronary artery disease	1.03e-05	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX4—coronary artery disease	1.03e-05	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT1A1—coronary artery disease	1.03e-05	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HADHA—coronary artery disease	1.02e-05	0.000274	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA1—coronary artery disease	1.01e-05	0.000271	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	1.01e-05	0.000271	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPA—coronary artery disease	9.98e-06	0.000268	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLCB3—coronary artery disease	9.66e-06	0.00026	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA5—coronary artery disease	9.56e-06	0.000257	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—P4HB—coronary artery disease	9.38e-06	0.000252	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLA2G1B—coronary artery disease	9.21e-06	0.000248	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	9.19e-06	0.000247	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—VCAN—coronary artery disease	8.68e-06	0.000233	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDOA—coronary artery disease	8.61e-06	0.000232	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	8.56e-06	0.00023	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—DCN—coronary artery disease	8.36e-06	0.000225	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDH2—coronary artery disease	8.13e-06	0.000219	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2C19—coronary artery disease	7.93e-06	0.000213	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3C2A—coronary artery disease	7.93e-06	0.000213	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LIPC—coronary artery disease	7.93e-06	0.000213	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HBA1—coronary artery disease	7.93e-06	0.000213	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOC3—coronary artery disease	7.88e-06	0.000212	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDLR—coronary artery disease	7.83e-06	0.000211	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC9A1—coronary artery disease	7.74e-06	0.000208	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTT1—coronary artery disease	7.74e-06	0.000208	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCLC—coronary artery disease	7.65e-06	0.000206	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CETP—coronary artery disease	7.65e-06	0.000206	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SDC1—coronary artery disease	7.56e-06	0.000203	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	7.51e-06	0.000202	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PSMA6—coronary artery disease	7.14e-06	0.000192	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PSMB5—coronary artery disease	7.14e-06	0.000192	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CTGF—coronary artery disease	6.98e-06	0.000188	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMGCR—coronary artery disease	6.91e-06	0.000186	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GOT2—coronary artery disease	6.91e-06	0.000186	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	6.78e-06	0.000182	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLCB1—coronary artery disease	6.36e-06	0.000171	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCA1—coronary artery disease	6.16e-06	0.000166	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GGT1—coronary artery disease	5.97e-06	0.000161	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GOT1—coronary artery disease	5.97e-06	0.000161	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—coronary artery disease	5.36e-06	0.000144	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	5.31e-06	0.000143	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMOX1—coronary artery disease	5.29e-06	0.000142	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAT—coronary artery disease	5.22e-06	0.00014	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOB—coronary artery disease	5.06e-06	0.000136	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—coronary artery disease	4.93e-06	0.000132	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPL—coronary artery disease	4.84e-06	0.00013	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX1—coronary artery disease	4.72e-06	0.000127	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CD36—coronary artery disease	4.6e-06	0.000124	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPP2CA—coronary artery disease	4.54e-06	0.000122	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTHFR—coronary artery disease	4.35e-06	0.000117	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AGT—coronary artery disease	4.14e-06	0.000111	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOE—coronary artery disease	4.05e-06	0.000109	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA1—coronary artery disease	4.01e-06	0.000108	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARG—coronary artery disease	3.53e-06	9.5e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—POMC—coronary artery disease	3.48e-06	9.36e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—coronary artery disease	3.17e-06	8.54e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NOS3—coronary artery disease	3.04e-06	8.17e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—coronary artery disease	2.78e-06	7.47e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.71e-06	4.6e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—coronary artery disease	1.4e-06	3.75e-05	CbGpPWpGaD
